8RLA image
Deposition Date 2024-01-02
Release Date 2025-01-15
Last Version Date 2026-01-07
Entry Detail
PDB ID:
8RLA
Keywords:
Title:
RECQL5:sfGFP hetero dimer assembled by Di-Gluebody - RECQL5 local refinement
Biological Source:
Source Organism(s):
Lama glama (Taxon ID: 9844)
Homo sapiens (Taxon ID: 9606)
Expression System(s):
Method Details:
Experimental Method:
Resolution:
3.03 Å
Aggregation State:
PARTICLE
Reconstruction Method:
SINGLE PARTICLE
Macromolecular Entities
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:ATP-dependent DNA helicase Q5
Gene (Uniprot):RECQL5
Chain IDs:B (auth: A)
Chain Length:442
Number of Molecules:1
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Molecule:Gluebody G5-006
Chain IDs:A (auth: K)
Chain Length:127
Number of Molecules:1
Biological Source:Lama glama
Ligand Molecules
Primary Citation
Covalently constrained 'Di-Gembodies' enable parallel structure solutions by cryo-EM.
Nat.Chem.Biol. 22 69 76 (2026)
PMID: 40817135 DOI: 10.1038/s41589-025-01972-7

Abstact

Whilst cryo-electron microscopy(cryo-EM) has become a routine methodology in structural biology, obtaining high-resolution cryo-EM structures of small proteins (<100 kDa) and increasing overall throughput remain challenging. One approach to augment protein size and improve particle alignment involves the use of binding proteins or protein-based scaffolds. However, a given imaging scaffold or linking module may prove inadequate for structure solution and availability of such scaffolds remains limited. Here, we describe a strategy that exploits covalent dimerization of nanobodies to trap an engineered, predisposed nanobody-to-nanobody interface, giving Di-Gembodies as modular constructs created in homomeric and heteromeric forms. By exploiting side-chain-to-side-chain assembly, they can simultaneously display two copies of the same or two distinct proteins through a subunit interface that provides sufficient constraint required for cryo-EM structure determination. We validate this method with multiple soluble and membrane structural targets, down to 14 kDa, demonstrating a flexible and scalable platform for expanded protein structure determination.

Legend

Protein

Chemical

Disease

Primary Citation of related structures
Feedback Form
Name
Email
Institute
Feedback